JOHN HOPE FRANKLIN CENTER
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1838-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.duke.edu
Interventions to Improve Hypertension Control and Reduce Cardiovascular Disease Risk
- Conditions
- Hypertension
- Interventions
- Behavioral: MD CQI-type interventionBehavioral: Lifestyle interventions to lower blood pressure for patients
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Duke University
- Target Recruit Count
- 574
- Registration Number
- NCT00201136
- Locations
- 🇺🇸
Duke University, Durham, North Carolina, United States
Comparing Paroxetine and Duloxetine on Cardiovascular Measures
- Conditions
- Depressive Symptoms
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2014-07-21
- Lead Sponsor
- Duke University
- Target Recruit Count
- 40
- Registration Number
- NCT00136383
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2014-09-16
- Lead Sponsor
- Duke University
- Target Recruit Count
- 33
- Registration Number
- NCT00134680
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸Siteman Cancer Center, Washington University, St. Louis, Missouri, United States
🇺🇸Lombardi Cancer Institute, Georgetown University Medical Center, Washington, District of Columbia, United States
A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ©) and/or Weekly Paclitaxel
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2005-08-19
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Duke University
- Target Recruit Count
- 94
- Registration Number
- NCT00131963
- Locations
- 🇺🇸
Duke Cancer Institute, Durham, North Carolina, United States
Comparison of Two Programs to Improve Blood Pressure Treatment Adherence
- Conditions
- Heart DiseasesHypertensionCardiovascular Diseases
- Interventions
- Behavioral: Nurse administeredDevice: BP Monitor
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2014-09-08
- Lead Sponsor
- Duke University
- Target Recruit Count
- 777
- Registration Number
- NCT00123058
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
Investigational Study of Psychological Intervention in Recipients of Lung Transplant (INSPIRE)
- Conditions
- DepressionLung Diseases
- Interventions
- Other: Usual CareBehavioral: Telephone-based coping skills/stress management
- First Posted Date
- 2005-06-06
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Duke University
- Target Recruit Count
- 389
- Registration Number
- NCT00113139
Second-Line Treatment for Patients With Platinum-Sensitive Ovarian Cancer
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2015-02-25
- Lead Sponsor
- Duke University
- Target Recruit Count
- 150
- Registration Number
- NCT00090610
- Locations
- 🇺🇸
Franklin Square Hospital Center/MedStar Health-Section of Hematology/Oncology, Baltimore, Maryland, United States
🇺🇸Hope: A Woman's Cancer Center, Asheville, North Carolina, United States
🇺🇸Columbia University College of Physicians and Surg, New York, New York, United States
Vaccine Therapy in Treating Patients With Metastatic Melanoma Who Are Undergoing Surgery for Lymph Node and Tumor Removal
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2004-08-25
- Last Posted Date
- 2013-03-25
- Lead Sponsor
- Duke University
- Registration Number
- NCT00003229
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
🇺🇸Cancer Center, University of Virginia HSC, Charlottesville, Virginia, United States
Carmustine Plus O(6)-Benzylguanine in Treating Patients With Recurrent or Progressive Gliomas of the Brain
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-08-16
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- Duke University
- Target Recruit Count
- 56
- Registration Number
- NCT00003348
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
Carboplatin in Patients With Progressive Gliomas
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2004-08-11
- Last Posted Date
- 2009-10-14
- Lead Sponsor
- Duke University
- Target Recruit Count
- 25
- Registration Number
- NCT00002749
- Locations
- 🇺🇸
Duke Comprehensive Cancer Center, Durham, North Carolina, United States
🇨🇦Hopital Sainte Justine, Montreal, Quebec, Canada